Medicines Act Notices




12 OCTOBER NEW ZEALAND GAZETTE 3693

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Colazide
Active Ingredient(s): Balsalazide disodium dihydrate 750mg
Dosage Form: Modified release capsule
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): Anabolic Inc, Irvine, California, United States of America
UCB Pharma SA, Chemin du Foriest, Braine-l'Alleud, Brussels, Belgium

Dated this 4th day of October 2000.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7513

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the schedule hereto:

Schedule

Product: Rexona Essentials
Active Ingredient(s): Piroctone olamine 0.5%w/w
Dosage Form: Shampoo
New Zealand Sponsor: Lever Rexona, A Division of Unilever New Zealand Limited
Manufacturer(s): Lever Rexona, North Rocks, New South Wales, Australia

Dated this 4th day of October 2000.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7514

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Atacand
Active Ingredient(s): Candesartan cilexetil 16mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Södertälje, Sweden

Product: Atacand
Active Ingredient(s): Candesartan cilexetil 4mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Södertälje, Sweden

Product: Atacand
Active Ingredient(s): Candesartan cilexetil 8mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Södertälje, Sweden



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 139


Gazette.govt.nz PDF NZ Gazette 2000, No 139





✨ LLM interpretation of page content

🏥 Consent to Distribution of Colazide

🏥 Health & Social Welfare
4 October 2000
Medicines Act, new medicine, Colazide, Balsalazide disodium dihydrate, modified release capsule, AstraZeneca Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to Distribution of Rexona Essentials

🏥 Health & Social Welfare
4 October 2000
Medicines Act, new related product, Rexona Essentials, Piroctone olamine, shampoo, Lever Rexona
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to Distribution of Changed Medicines (Atacand)

🏥 Health & Social Welfare
4 October 2000
Medicines Act, changed medicines, Atacand, Candesartan cilexetil, tablets, AstraZeneca Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation